Cargando…
Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects
BACKGROUND: A large body of evidence suggests that thyroid hormones (THs) are beneficial for the treatment of cardiovascular disorders. We have shown that 3 days of triiodo-L-thyronine (T3) treatment in myocardial infarction (MI) rats increased left ventricular (LV) contractility and decreased myocy...
Autores principales: | Rajagopalan, Viswanathan, Zhang, Youhua, Ojamaa, Kaie, Chen, Yue-feng, Pingitore, Alessandro, Pol, Christine J., Saunders, Debra, Balasubramanian, Krithika, Towner, Rheal A., Gerdes, A. Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794221/ https://www.ncbi.nlm.nih.gov/pubmed/26981865 http://dx.doi.org/10.1371/journal.pone.0151413 |
Ejemplares similares
-
Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury
por: Rajagopalan, Viswanathan, et al.
Publicado: (2017) -
3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice
por: Moreno, Maria, et al.
Publicado: (2016) -
Anti-Apoptotic Effects of 3,3’,5-Triiodo-L-Thyronine in the Liver of Brain-Dead Rats
por: Rebolledo, Rolando A., et al.
Publicado: (2015) -
Proteomic approaches for the study of tissue specific effects of 3,5,3′-triiodo-L-thyronine and 3,5-diiodo-L-thyronine in conditions of altered energy metabolism
por: Silvestri, Elena, et al.
Publicado: (2014) -
Adverse transverse-tubule remodeling in a rat model of heart failure is attenuated with low-dose triiodothyronine treatment
por: An, Shimin, et al.
Publicado: (2019)